F.D.A. Confirms Widespread Shortages of Adderall
The agency cited Teva ’s continuing supply problems as well as those of other drug makers struggling to fill the gap. (Source: NYT Health)
Source: NYT Health - October 13, 2022 Category: Consumer Health News Authors: Christina Jewett Tags: Drugs (Pharmaceuticals) Attention Deficit Hyperactivity Disorder Telemedicine Drugstores Generic Brands and Products Shortages Food and Drug Administration Teva Pharmaceutical Industries Ltd Source Type: news

FDA Says ADHD Medication Adderall Is in Short Supply
THURSDAY, Oct. 13, 2022 -- People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday. The Adderall and Adderall IR... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 13, 2022 Category: Pharmaceuticals Source Type: news

Adderall Shortage Expected to Continue for Months in the U.S.
Teva Pharmaceutical Industries Ltd.’s shortage of Adderall is expected to last through March, longer than the two to three months the company said last week, according to U.S. regulators. The popular treatment for attention-deficit/hyperactivity disorder has been in short supply since at least August, leaving people racing to fill prescriptions and find pharmacies with the elusive medication in stock. Demand for the drug is at an all-time high, and Teva sells more Adderall in the U.S. than any other drug company. Teva “is experiencing ongoing intermittent manufacturing delays,” the FDA said on its website...
Source: TIME: Health - October 13, 2022 Category: Consumer Health News Authors: Ike Swetlitz/Bloomberg Tags: Uncategorized Drugs healthscienceclimate wire Source Type: news

ADHD label may increase risk of self-harm in teens, study suggests
Diagnosing attention-deficit/hyperactivity disorder in adolescents doesn't improve their self-reported quality of life compared with teens with similar behaviors but no diagnosis. And it may increase risk of self-harm. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 13, 2022 Category: Consumer Health News Source Type: news

FDA Says ADHD Med Adderall Is in Short Supply
THURSDAY, Oct. 13, 2022 -- People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday. The Adderall and Adderall IR... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 13, 2022 Category: General Medicine Source Type: news

Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic disorder: a nationwide longitudinal cohort study in South Korea - Park J, Lee DY, Kim C, Lee YH, Yang SJ, Lee S, Kim SJ, Lee J, Park RW, Shin Y.
BACKGROUND: Methylphenidate (MPH) is the most frequently prescribed medication for the treatment of attention deficit hyperactivity disorder (ADHD). However, the safety of its long-term use remain unclear. In particular, real-world evidence of long-term MP... (Source: SafetyLit)
Source: SafetyLit - October 13, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

These Canadians with ADHD are finding acceptance and understanding online
As is common for people with attention deficit hyperactivity disorder, 27-year-old Maylee Bossier of Chatham, Ont., said she had long put off making an appointment to get a diagnosis, as recommended by her therapist. Then the pandemic hit. (Source: CBC | Health)
Source: CBC | Health - October 8, 2022 Category: Consumer Health News Tags: News/Canada/Windsor Source Type: news

Improve support for people with ADHD
This study, managed by Exeter University, funded by the National Institute for Health and Care Research, aims to find out about primary care services for young people and adults with attention deficit hyperactivity disorder (ADHD) in England. (Source: NHS Networks)
Source: NHS Networks - October 6, 2022 Category: UK Health Source Type: news

ADHD and dangerous driving in emerging adults: the moderating role of family climate for road safety - Burns AB, Garner AA, Avion A, Becker SP, Kofler MJ, Jarrett MA, Luebbe AM, Burns GL.
Dangerous driving accounts for 95% of driving fatalities among emerging adults. Emerging adult drivers exhibiting symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) are at greater risk for motor vehicle crashes and engaging in unsafe driving pract... (Source: SafetyLit)
Source: SafetyLit - October 3, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Using position rather than color at the traffic light - covariation learning-based deviation from instructions in attention deficit/hyperactivity disorder - Gaschler R, Ditsche-Klein BE, Kriechbaumer M, Blech C, Wenke D.
Based on instructions people can form task representations that shield relevant from seemingly irrelevant information. It has been documented that instructions can tie people to a particular way of performing a task despite that in principle a more efficie... (Source: SafetyLit)
Source: SafetyLit - October 1, 2022 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

A longitudinal investigation of parental ratings and performance metrics for executive functioning and symptom severity in clinically referred youth with ADHD - Tallberg P, Rastam M, Hallin AL, Perrin S, Gustafsson P.
There remains a knowledge gap concerning the persistence of attention deficit hyperactivity disorder (ADHD) over the longer term. The current study aimed to investigate the change in parent-rated, and performance-based metrics of executive functioning (EF)... (Source: SafetyLit)
Source: SafetyLit - September 26, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Flint Is Still Shaken by its Water Crisis —and Residents Are Experiencing Long-Term Mental-Health Issues
The Jackson, Mississippi, water crisis this summer is a troubling reminder that some American communities are still failing to provide safe water to their residents. After Jackson’s primary water treatment plant failed, around 180,000 people were left with little or no sanitary water. It was reminiscent of the crisis in Flint, Michigan, which rose to broad public awareness in 2015, when residents learned that they’d been poisoned for months by drinking water containing bacteria, disinfectant byproducts, and lead. The crisis is far from a distant memory in Flint. According to a new survey of nearly 2,000 adult c...
Source: TIME: Health - September 22, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized healthscienceclimate Public Health Source Type: news

Training inhibitory control in adolescents with elevated attention deficit hyperactivity disorder traits: a randomised controlled trial of the Alfi Virtual Reality programme - McKay E, Kirk H, Coxon J, Courtney D, Bellgrove M, Arnatkeviciute A, Cornish K.
INTRODUCTION: Attention deficit hyperactivity disorder (ADHD) is characterised by significant deficits in attention and inhibition. These deficits are associated with negative sequelae that emerge in childhood and often continue throughout adolescence. Des... (Source: SafetyLit)
Source: SafetyLit - September 22, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Heart Disease Can Plague Adults With ADHD
TUESDAY Sept. 20, 2022 -- New research suggests that attention deficit hyperactivity disorder (ADHD) may trigger more than just psychiatric complications: Adults suffering from ADHD may also be more likely to develop some type of cardiovascular... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 20, 2022 Category: General Medicine Source Type: news

ADHD Is Risk Factor for Cardiovascular Diseases
MONDAY, Sept. 19, 2022 -- Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for cardiovascular diseases, according to a study published online Sept. 8 in World Psychiatry. Lin Li, Ph.D., from Örebro University in Sweden, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 19, 2022 Category: Pharmaceuticals Source Type: news